Failure of once-daily vancomycin for staphylococcal endocarditis

Area of Science:

• Infectious Diseases
• Pharmacology
• Cardiology

Background:

• Staphylococci are significant hospital-acquired pathogens, leading to increased vancomycin use.
• Once-daily vancomycin dosing protocols were developed for simplified antibiotic administration.
• Prosthetic valve endocarditis is a severe infection requiring effective antimicrobial therapy.

Observation:

• A patient with Staphylococcus aureus prosthetic valve endocarditis and normal renal function was treated with vancomycin once daily.
• The patient failed to respond to the once-daily vancomycin regimen.

Findings:

• Switching to a conventional 12-hour dosing interval for vancomycin successfully cured the patient's infection.
• This suggests that standard dosing may be more effective for certain severe staphylococcal infections.

Implications:

• Once-daily vancomycin may not be suitable for all patients with severe Staphylococcus aureus infections, such as prosthetic valve endocarditis.
• Conventional vancomycin dosing intervals should be considered for complex staphylococcal infections.
• Further research is needed to determine optimal vancomycin dosing strategies for serious infections.